
Formats: [HTML](/news/2016/03/31/the-u-s-federal-trade-commission-files-an-anti-trust-suit-against-endo-pharmaceuticals-inc-and-several-other-drug-companies-for-using-pa.html)  [JSON](/news/2016/03/31/the-u-s-federal-trade-commission-files-an-anti-trust-suit-against-endo-pharmaceuticals-inc-and-several-other-drug-companies-for-using-pa.json)  [XML](/news/2016/03/31/the-u-s-federal-trade-commission-files-an-anti-trust-suit-against-endo-pharmaceuticals-inc-and-several-other-drug-companies-for-using-pa.xml)  

### [2016-03-31](/news/2016/03/31/index.md)

##### U.S. Federal Trade Commission
# The U.S. Federal Trade Commission files an anti-trust suit against Endo Pharmaceuticals, Inc., and several other drug companies for using pay-for-delay settlements to block consumers' access to lower-cost generic versions of pain medications, Opana ER and Lidoderm. 




### Sources:

1. [StreetInsider.com](http://www.streetinsider.com/Corporate+News/FTC+Suit+Alleges+Endo+%28ENDP%29+Entered+into+Pay-for-Delay+Patent+Settlements+with+Impax+%28IPXL%29+and+Watson+to+Delay+Generic+Versions+of+Branded+Drugs+Opana+ER+and+Lidoderm/11462674.html)

### Related:

1. [The U.S. Food and Drug Administration asks pharmaceutical manufacturer Endo International plc to withdraw its long-lasting (12 hours) opioid painkiller, Opana ER, from the market after an FDA panel concluded the drug's benefits no longer outweighed the risks of abuse. Endo is evaluating its options. ](/news/2017/06/8/the-u-s-food-and-drug-administration-asks-pharmaceutical-manufacturer-endo-international-plc-to-withdraw-its-long-lasting-12-hours-opioid.md) _Context: Endo International plc, Opana ER_
2. [Uber agrees to pay $20 million to settle U.S. Federal Trade Commission claims the company exaggerated prospective earnings and downplayed the costs of buying-leasing a car when recruiting new drivers. ](/news/2017/01/19/uber-agrees-to-pay-20-million-to-settle-u-s-federal-trade-commission-claims-the-company-exaggerated-prospective-earnings-and-downplayed-th.md) _Context: U.S. Federal Trade Commission_
3. [The U.S. Federal Trade Commission gives the antitrust go ahead to Abbott Laboratories in its acquisition of St. Jude Medical. ](/news/2016/12/27/the-u-s-federal-trade-commission-gives-the-antitrust-go-ahead-to-abbott-laboratories-in-its-acquisition-of-st-jude-medical.md) _Context: U.S. Federal Trade Commission_
4. [U.S. District Judge Emmet Sullivan blocks the $6.3 billion merger of major office supply companies Staples and Office Depot, finding it would result in reduced competition and higher prices. The companies announce they are abandoning the deal. ](/news/2016/05/10/u-s-district-judge-emmet-sullivan-blocks-the-6-3-billion-merger-of-major-office-supply-companies-staples-and-office-depot-finding-it-woul.md) _Context: reduced competition and higher prices_
5. [Halliburton Co. and Baker Hughes Inc., the second- and third-largest oilfield service firms, announce the cancellation of their $28 billion merger which has faced opposition from U.S. and European antitrust regulators. Halliburton will reportedly have to pay Baker Hughes a $3.5 billion termination fee if the deal is called off. ](/news/2016/05/1/halliburton-co-and-baker-hughes-inc-the-second-and-third-largest-oilfield-service-firms-announce-the-cancellation-of-their-28-billion.md) _Context: reduced competition and higher prices_
